Anthos Therapeutics

Business Area(s): 
Description: 

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for high-risk cardiovascular patients. Anthos’s lead program is MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway

Location(s): 
Cambridge MA
United States